Cardiovascular risk factors profile in patients with acute coronary syndrome with particular reference to left ventricular ejection fraction
• 2017
Publication Information
Authors
Sheeren Khaled, Rajaa Matahen
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Acute coronary syndrome (ACS) remains a leading cause of death in the United States.
Numerous studies have shown that the degree of LV systolic dysfunction is a major if not the most
important determinant of long-term outcome in ACS.
Objectives: To identify the most important risk factors and other clinical predictors which might have
impact on left ventricular ejection fraction in patients with ACS.
Results: The total patients (299) admitted to our center from July, 2015 till December, 2015; with
established diagnosis of ACS were classified in to two groups: Group I: 193 patients with impaired LVEF
< 40% (64.5%), Group II: 106 patients with LVEF equal or > 40% (35.5%). The patients of group I were
significant elderly compared to those of group II (60.9
11.2 vs 56.9
10.6; p = 0.002), had significant
history of DM and CKD (66.3% and 31.1% VS 49.1% and 19.8%; p = 0.004 and 0.036 respectively), presented
mainly with STEMI- ACS (51.3% VS 28.3% respectively; p < 0.001) with +v cardiac biomarker (troponin)
(90.2% VS 66.0%; p < 0.001). Moreover, patients of group I had more significant ischemic MR compared to
the patients of group II (24.9% VS 3.8% respectively; p < 0.001) with higher rate of LV thrombus discovered
by echocardiography (25.4% VS 1.9%; p < 0.001). Extensive significant CAD disease was observed to be
higher among patients of group I (69.4% VS 57.5%; p = 0.039) and those patients treated mainly with PCI
revascularization therapy (68.9% VS 52.8%; p = 0.002) compared to patients of group II who mainly
treated medically (34.9% VS 17.6 %; p < 0.001). Multiple logistic regression analysis demonstrated that
DM (odd ratio (OR): 2.64, 95% confidence interval (CI): 1.45-4.79, P = 0.01), presence of significant
ischemic MR (OR: 13.7, 95% CI:2.84-66.1, p = 0.001)and presence of significantly diseased coronary vessels
(odd ratio (OR): 5.06, 95% confidence interval (CI): 1.14-22.6, P = 0.033,) all were independent predictors
for significant LV dysfunction (LVEF < 40%) which predict poor outcome in ACS patients.
Conclusion: We concluded that DM, presence of significant ischemic MR, and increased number, severity
of diseased coronaries all were independent predictors of LV dysfunction (LVEF < 40%) which is known to
predict poor outcome. Identification of those risk predictors upon patient evaluation could be helpful to
identify high risk-patients, in need of particular care, aggressive therapy and close follow-up to improve
their poor outcome.
Numerous studies have shown that the degree of LV systolic dysfunction is a major if not the most
important determinant of long-term outcome in ACS.
Objectives: To identify the most important risk factors and other clinical predictors which might have
impact on left ventricular ejection fraction in patients with ACS.
Results: The total patients (299) admitted to our center from July, 2015 till December, 2015; with
established diagnosis of ACS were classified in to two groups: Group I: 193 patients with impaired LVEF
< 40% (64.5%), Group II: 106 patients with LVEF equal or > 40% (35.5%). The patients of group I were
significant elderly compared to those of group II (60.9
11.2 vs 56.9
10.6; p = 0.002), had significant
history of DM and CKD (66.3% and 31.1% VS 49.1% and 19.8%; p = 0.004 and 0.036 respectively), presented
mainly with STEMI- ACS (51.3% VS 28.3% respectively; p < 0.001) with +v cardiac biomarker (troponin)
(90.2% VS 66.0%; p < 0.001). Moreover, patients of group I had more significant ischemic MR compared to
the patients of group II (24.9% VS 3.8% respectively; p < 0.001) with higher rate of LV thrombus discovered
by echocardiography (25.4% VS 1.9%; p < 0.001). Extensive significant CAD disease was observed to be
higher among patients of group I (69.4% VS 57.5%; p = 0.039) and those patients treated mainly with PCI
revascularization therapy (68.9% VS 52.8%; p = 0.002) compared to patients of group II who mainly
treated medically (34.9% VS 17.6 %; p < 0.001). Multiple logistic regression analysis demonstrated that
DM (odd ratio (OR): 2.64, 95% confidence interval (CI): 1.45-4.79, P = 0.01), presence of significant
ischemic MR (OR: 13.7, 95% CI:2.84-66.1, p = 0.001)and presence of significantly diseased coronary vessels
(odd ratio (OR): 5.06, 95% confidence interval (CI): 1.14-22.6, P = 0.033,) all were independent predictors
for significant LV dysfunction (LVEF < 40%) which predict poor outcome in ACS patients.
Conclusion: We concluded that DM, presence of significant ischemic MR, and increased number, severity
of diseased coronaries all were independent predictors of LV dysfunction (LVEF < 40%) which is known to
predict poor outcome. Identification of those risk predictors upon patient evaluation could be helpful to
identify high risk-patients, in need of particular care, aggressive therapy and close follow-up to improve
their poor outcome.
Staff Members - Benha University